fbpx
Title Image

WeekWatch -‘Decline in the value of sterling’ December 2020

WeekWatch -‘Decline in the value of sterling’ December 2020

“Despite the fact that deadlines have been missed over and over, we think it is responsible at this point to go the extra mile,” read a joint statement yesterday from European Commission President Ursula von der Leyen and UK Prime Minister Boris Johnson.

Details were thin on the ground as this week began, with no deadline set for this extension of the talks, and press reports suggesting they could go on until Christmas.

In markets, the most notable single effect of last week’s uncertainty was a decline in the value of sterling. As a no-deal outcome started to look more likely towards the end of the week, the pound fell by about 2% against the dollar. For investors in large UK companies, a temporarily weaker pound isn’t necessarily a bad thing, because many of the largest companies earn lots of their revenue abroad. The pound climbed on Monday this week in early trading.

There are clearly risks for sterling due to the ongoing talks, noted Chris Ralph, Chief Global Strategist at St. James’s Place. However, he also suggested that for the pound to fall to the lows seen earlier in the year, the trade negotiations would have to end messily, with a major disagreement.

Investors still expect a deal to take place, with many banks and fund managers still saying that a trade agreement is their base case scenario. However, they are cautious about the disruption that a failure to reach an agreement would cause. Capital Economics suggests that much of the market impact has been priced in by investors already, given the lack of distance between no-deal and deal caused by the path we’ve gone down in the last couple of years.

However, COVID-19 is still the largest driver of markets by far and will remain so even in the case of no deal, notes Mark Dowding of BlueBay Asset Management, co-manager of the St. James’s Place Strategic Income fund.

“The economic impact coming from this outcome is likely to still pale into insignificance compared to the result of the coronavirus,” he adds.

When it comes to predicting the future performance of UK equities, it’s important to remember that, by many metrics, UK companies appear to be undervalued. Richard Colwell of Columbia Threadneedle (manager of the St. James’s Place Strategic Managed fund) believes that UK equities are set to enjoy a resurgence. He says: “On many measures, the UK market is as cheap as it’s been since the ‘70s.”

The UK is undervalued compared to other equity markets, being packed with quality companies whose true values are higher than current prices, he argues. He points to events such as September’s purchase of William Hill by US gambling giant Caesars Entertainment. The fact that the deal took place in the middle of the COVID-19 pandemic, and with Brexit trade negotiations still ongoing, demonstrates that quality businesses are attractive to investors even in challenging environments.

Colwell adds: “There are prize assets available because we, the investment community, continue to be too timid and too bearish on the intrinsic value of UK stocks.”

While Brexit negotiations generated headlines last week, markets were also responding to the same forces that have been driving them throughout the year. Vaccine developments, COVID-19 cases, and economic data all had an impact on risk assets last week.

There was mixed news in the US, as jobs data and COVID-19 case numbers pointed towards the ongoing damage created by the pandemic. However, hopes also grew of an economic stimulus package being agreed in the near term.

US COVID-19 case numbers painted a less-than-rosy picture last week, reaching an average of 210,000 new confirmed cases per day, showing that the world’s largest economy has a long way to go in the battle against the pandemic. On the positive side, though, the rate of increase appeared to be slowing by the end of the week.

However, on Wednesday, the White House made a new fiscal stimulus offer to the Democrats, raising hopes that the much-needed funds will help spur the economic recovery. The parties have been agreed on the need for more stimulus for months but are gridlocked over its size and some of the conditions they want attached.

Meanwhile, the European Central Bank (ECB) announced at a meeting that it will extend its bond-buying programme by nine months and an additional €500 billion. The market reaction was fairly muted because the announcement was in line with investor expectations. The ECB programme is one of a series of similar measures by global central banks that have been crucial to supporting markets since the pandemic took hold in March this year.

Finally, last week saw an important milestone in the effort to control COVID-19, when a UK grandmother became the first person to receive the Pfizer/BioNTech vaccine. Margaret Keenan, whose 91st birthday is this week, said the jab was the “best early birthday present”.”

BlueBay are fund managers for St. James’s Place.

The information contained is correct as at the date of the article. The information contained does not constitute investment advice and is not intended to state, indicate or imply that current or past results are indicative of future results or expectations. Where the opinions of third parties are offered, these may not necessarily reflect those of St. James’s Place.

FTSE International Limited (“FTSE”) © FTSE 2020. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under licence. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

© S&P Dow Jones LLC 2020; all rights reserved

The ‘St. James’s Place Partnership’ and the titles ‘Partner’ and ‘Partner Practice’ are marketing terms used to describe St. James’s Place representatives.

Members of the St. James’s Place Partnership in the UK represent St. James’s Place Wealth Management plc, which is authorised and regulated by the Financial Conduct Authority.

St. James’s Place Wealth Management plc Registered Office: St. James’s Place House, 1 Tetbury Road, Cirencester, Gloucestershire, GL7 1FP, United Kingdom.  Registered in England Number 4113955.

 

Proud to be supporters of...

Abbeygate House
88/89 Whiting Street
Bury St Edmunds
Suffolk, IP33 1NX
01284 703422
abbeygatewm@sjpp.co.uk

Registered in England and Wales
Company No.06803554

Representing only St. James's Place Wealth Management plc (which is authorised and regulated by the Financial Conduct Authority) for the purpose of advising solely on the Group's wealth management products and services, more details of which are set out on the Group's website www.sjp.co.uk/products. The titles 'Partnership', 'Partner' and 'Partner Practice' are the marketing terms used to describe St. James's Place Wealth Management representatives.